Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lagier, J.-C., Armougom, F., Million, M., Hugon, P., Pagnier, I., Robert, C., Bittar, F., Fournous, G., Gimenez, G., Maraninchi, M., Trape, J.-F., Koonin, E. V., La Scola, B., & Raoult, D. (2012). Microbial culturomics: paradigm shift in the human gut microbiome study. Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, 18(12), 1185–1193.
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health:
Negative
Source: clinical sources (blood, sputum, wound) and human faeces
DNA G+C(%): 36.6-37.4
|
|
|
---|
Monosaccharide O/F | Oligosaccharide O/F | Polysaccharide O/F | Polyol O/F | Other O/F |
|
|
|
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
amoxicillin: SensRNG: (0.008-0.125)
ampicillin: SensRNG: (0.008-0.25)
benzyl-pen: SensRNG: (0.016-0.5)
piperacillin: SensRNG: (0.063-1)
imipenem: SensRNG: (0.016-0.032)
|
cefaclor: RNG: (0.25-4)
cefazolin: SensRNG: (0.125-2)
ceftazidime: RNG: (2-64)
|
gentamicin: R(16-64)
|
erythromycin: SensRNG: (0.125-0.5)
|
ciprofloxacin: RNG: (1-4)
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
minocycline: SensRNG: (0.016-8)
|
vancomycin: SensRNG: (0.25-0.5)
|
|
SXT: R(16->256)
|
|